Atlas Trials

Bladder Carcinoma in Situ (CIS)

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Bladder Carcinoma in Situ (CIS)

RecordFirmDate
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) (NCT05024773)Fidia Farmaceutici s.p.a.2022-12-29
Study of ONCOFID-P-B™ (PACLITAXEL-HYALURONIC ACID) (NCT04798703)Fidia Farmaceutici s.p.a.2017-05-24

Track Bladder Carcinoma in Situ (CIS) automatically

Every clearance here is in the API, with alerts when new ones post.